StockData
Optex Systems Holdings Inc logo

Optex Systems Holdings Inc (OPXS) stock analysis

OPXSNasdaqOptical Instruments & LensesFiscal year ends September 28
Financials through Q3 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 11, 2026Score 20/3033% below fair value
$8.52−0.06 (-0.70%)

Close on Nov 13, 2026Market cap $59.30MP/E 15.5Yield –

StockData Score

Prices as of Nov 13, 2026How the score works

Value6Growth3Performance5Health6Dividend0

Solid20 of 30 checks passed

Optex Systems passes 20 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
6/6
Growth
3/6
Past performance
5/6
Financial health
6/6
Dividend
0/6

What stands out

  • Margin of safety over 20%

    The price is 32.8% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $8.52 is below our fair value estimate of $12.68.

  • Return on equity over 15%

    Return on equity was 15.3% over the last twelve months and averaged 17.3% over five years.

  • Return on capital over 10%

    Return on invested capital was 22.3%, above the 10% that usually covers the cost of capital.

What to watch

  • Earnings growth not accelerating

    Net income grew -24.3% over the last twelve months, against a 5-year average of 23.0% a year.

  • Growing slower than the industry

    Revenue grew 0.8% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.3%.

  • Net margin below its 5-year average

    Net margin was 9.8% over the last twelve months, against a 5-year average of 10.0%.

  • No dividend

    Optex Systems has not paid a dividend in the last twelve months.

Valuation6/6
  • P/E below its 5-year median

    Optex Systems's P/E of 15.5 is below its own 5-year median of 16.6.

  • P/E below the industry

    Optex Systems's P/E of 15.5 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 35.0.

  • EV/EBITDA below its 5-year median

    Optex Systems's EV/EBITDA of 9.3 is below its 5-year median of 11.0.

  • P/B below the industry

    Optex Systems's price-to-book of 2.14 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.13.

  • Trading below fair value

    The share price of $8.52 is below our fair value estimate of $12.68.

  • Margin of safety over 20%

    The price is 32.8% below fair value, more than the 20% cushion we look for.

Growth3/6
  • Revenue growing 10%+ a year

    Revenue grew 22.7% a year over the last three fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 66.6% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -24.3% over the last twelve months, against a 5-year average of 23.0% a year.

  • Growing slower than the industry

    Revenue grew 0.8% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.3%.

  • Guidance unchanged

    The latest outlook (full-year full-year revenue guidance, Aug 11, 2026) was maintained, so it neither adds nor takes away points.

  • Gross margin improving

    Gross margin was 30.7% over the last twelve months, against 28.0% a year earlier.

Past performance5/6
  • Return on equity over 15%

    Return on equity was 15.3% over the last twelve months and averaged 17.3% over five years.

  • Return on capital over 10%

    Return on invested capital was 22.3%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Optex Systems's return on equity of 15.3% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

  • Earnings grew over 5 years

    Net income grew 23.0% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 9.8% over the last twelve months, against a 5-year average of 10.0%.

  • Net margin above the industry

    Optex Systems's net margin of 9.8% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -2.4%.

Financial health6/6
  • No debt

    Optex Systems has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term assets cover short-term debts

    Current assets are 7.09 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 10.39; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    Optex Systems has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$12.68

The share price is 33% below this estimate.

20%+ below
Near fair value
20%+ above
$8.52Price$12.68Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E25.8×16.6×35.0×$14.1740%
EV/EBITDA17.2×11.0×23.5×$14.9735%
P/B2.8×2.4×3.1×$11.0410%
Earnings power7.6% cost of equity––$4.4715%
Fair value$12.68100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 16.6
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 35.0

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$117.09K
Value traded per 1% price move
$80.30K

Downside

Medium risk

Typical loss in a bad month
23.0%
Volatility (annualized)
58%
Sharpe ratio, 1 year
-0.77
Beta to the S&P 500 (5Y)
0.43

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

29.2%+5.7 pts over 5 years

Operating margin

17.3%+6.1 pts over 5 years

Net margin

12.5%+5.4 pts over 5 years

See a number that looks wrong?